SEARCH

SEARCH BY CITATION

References

  • Azevedo EC, Rios MK, Fukushima K & Campos-Takaki GM (1993) Bacitracin production by a new strain of Bacillus subtilis. Extraction, purification, and characterization. Appl Biochem Biotech 42: 17.
  • Baba T, Takeuchi F, Kuroda M et al. (2002) Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359: 18191827.
  • Chalker AF, Ingraham KA, Lunsford RD, Bryant AP, Bryant J, Wallis NG, Broskey JP, Pearson SC & Holmes DJ (2000) The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence. Microbiology 146: 15471553.
  • Fischbach MA & Walsh CT (2009) Antibiotics for emerging pathogens. Science 325: 10891093.
  • Gardete S, Wu SW, Gill S & Tomasz A (2006) Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob Agents Ch 50: 34243434.
  • Grundmann H, Aires-de-Sousa M, Boyce J & Tiemersma E (2006) Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368: 874875.
  • Howden BP, Stinear TP, Allen DL, Johnson PD, Ward PB & Davies JK (2008) Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Ch 52: 37553762.
  • Ito T, Okuma K, Ma XX, Yuzawa H & Hiramatsu K (2003) Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Update 6: 4152.
  • Johnson BA, Anker H & Meleney FL (1945) Bacitracin: a new antibiotic produced be a member of the B. subtilis group. Science 102: 376377.
  • Komatsuzawa H, Fujiwara T, Nishi H, Yamada S, Ohara M, McCallum N, Berger-Bachi B & Sugai M (2004) The gate controlling cell wall synthesis in Staphylococcus aureus. Mol Microbiol 53: 12211231.
  • Kreiswirth B, Lofdahl S, Betley M, O'Reilly M, Schlievert P, Bergdoll M & Novick R (1983) The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305: 709712.
  • Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H & Hiramatsu K (2003) Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 49: 807821.
  • Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE & Otto M (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66: 11361147.
  • Luong TT & Lee CY (2006) The arl locus positively regulates Staphylococcus aureus type 5 capsule via an mgrA-dependent pathway. Microbiology 152: 31233131.
  • Manson JM, Keis S, Smith JMB & Cook GM (2004) Acquired bacitracin resistance in Enterococcus faecalis is mediated by an ABC transporter and a novel regulatory protein, BcrR. Antimicrob Agents Ch 48: 37433748.
  • Matsuo M, Kato F, Oogai Y, Kawai T, Sugai M & Komatsuzawa H (2010) Distinct two-component systems in methicillin-resistant Staphylococcus aureus can change the susceptibility to antimicrobial agents. J Antimicrob Chemoth 65: 15361537.
  • Meehl M, Herbert S, Götz F & Cheung A (2007) Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Ch 51: 26792689.
  • Nishi H, Komatsuzawa H, Fujiwara T, McCallum N & Sugai M (2004) Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Ch 48: 48004807.
  • Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48: 14291449.
  • Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, Kobayashi K & Ogasawara N (2003) The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol Microbiol 49: 11351144.
  • Pietiäinen M, François P, Hyyryläinen HL, Tangomo M, Sass V, Sahl HG, Schrenzel J & Kontinen VP (2009) Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10: 429.
  • Podlesek Z, Comino A, Herzog-Velikonja B, Zgur-Bertok D, Komel R & Grabna M (1995) Bacillus licheniformis bacitracin-resistance ABC transporter: relationship to mammalian multidrug resistance. Mol Microbiol 16: 969976.
  • Rietkötter E, Hoyer D & Mascher T (2008) Bacitracin sensing in Bacillus subtilis. Mol Microbiol 68: 768785.
  • Sakoulas G, Eliopoulos GM, Moellering RCJ, Wennersten C, Venkataraman L, Novick RP & Gold HS (2002) Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Ch 46: 14921502.
  • Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • Stone KJ & Strominger JL (1971) Mechanism of action of bacitracin: complexation with metal ion and C 55 – isoprenyl pyrophosphate. P Natl Acad Sci USA 68: 32233227.
  • Subrata S, Jiwen S & Lee CY (1997) Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus. J Bacteriol 179: 16141621.
  • Tsuda H, Yamashita Y, Shibata Y, Nakano Y & Koga T (2002) Genes involved in bacitracin resistance in Streptococcus mutans. Antimicrob Agents Ch 46: 37563764.
  • Tsuji B T, Rybak MJ, Lau KL & Sakoulas G (2007) Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob Agents Ch 51: 10891091.
  • Yin S, Daum RS & Boyle-Vavra S (2006) VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Antimicrob Agents Ch 50: 336343.